Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LLSDP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
9MW-2921
|
|||||
| Synonyms |
9MW 2921; 9MW-2921; 9MW2921
Click to Show/Hide
|
|||||
| Organization |
Mabwell (Shanghai) Bioscience Co., Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
DNA topoisomerase-I inhibitor
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Reactive Cysteines
|
|||||
